Tetra Pharm Technologies

Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound

by

The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug – TPT0301. COPENHAGEN, Denmark , June 13, 2023 /PRNewswire/ — In a recent In-Vitro study of TPT0301, Tetra Pharm Technologies’s novel drug delivery technology was compared against more commonly utilized formulations for drug delivery in the oral cavity. A … Read more

Tetra Pharm Technologies gibt erfolgreichen In-vitro-Test zur Wirkstofffreigabe einer neuen analgetischen Verbindung bekannt

by

Das dänische Biotech-Unternehmen Tetra Pharm Technologies gibt vielversprechende Ergebnisse aus präklinischen Tests seines schmerzlindernden Medikaments TPT0301 bekannt. KOPENHAGEN, Dänemark, 13. Juni 2023 /PRNewswire/ — In einer kürzlich durchgeführten In-vitro-Studie mit TPT0301 wurde die neuartige Arzneimittelverabreichungstechnologie von Tetra Pharm Technologies mit gängigeren Formulierungen für die Verabreichung von Medikamenten in der Mundhöhle verglichen. Für die Freisetzungstests sowie … Read more

Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound

by

The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug – TPT0301. COPENHAGEN, Denmark, June 13, 2023 /PRNewswire/ — In a recent In-Vitro study of TPT0301, Tetra Pharm Technologies’s novel drug delivery technology was compared against more commonly utilized formulations for drug delivery in the oral cavity. A … Read more

Tetra Pharm Technologies annonce la réussite du test in vitro de libération d’un nouveau composé analgésique

by

La société de biotechnologie danoise Tetra Pharm Technologies annonce les résultats prometteurs des essais précliniques de son médicament antidouleur – TPT0301. COPENHAGUE, Danemark, 13 juin 2023 /PRNewswire/ — Dans une récente étude in vitro du TPT0301, la nouvelle technologie d’administration de médicaments de Tetra Pharm Technologies a été comparée à des formules plus couramment utilisées pour … Read more

Tetra Pharm Technologies refuerza el consejo de administración

by

La empresa danesa de biotecnología Tetra Pharm Technologies amplía su consejo de administración con la incorporación de Steen Jakobsen como director Financiero y Jacob Schlundt como director de Marketing. Como resultado, el consejo de administración de la empresa cuenta ahora con 6 miembros. COPENHAGUE, Dinamarca, 16 de mayo de 2023 /PRNewswire/ — Tetra Pharm Technologies desarrolla … Read more

Tetra Pharm Technologies strengthens management board

by

The Danish biotech company, Tetra Pharm Technologies, is expanding its management board with Mr. Steen Jakobsen as Chief Financial Officer (CFO) and Mr. Jacob Schlundt as Chief Marketing Officer (CMO). As a result, the company’s management board now has 6 members. COPENHAGEN, Denmark, May 16, 2023 /PRNewswire/ — Tetra Pharm Technologies develops and manufactures pharmaceutical drugs … Read more